December 15th, 2015

Pfizer applies for emergency use of Covid-19 vaccine amid testing bottleneck: CNBC After Hours

Pfizer submitted its Covid-19 vaccine to the FDA for emergency authorization today, kicking off the first step of the approval and deployment process.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.